Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesSurvival in Malignant Peripheral Nerve Sheath Tumours: A Comparison between Sporadic and Neurofibromatosis Type 1-Associated Tumours
Sarcoma, 06/16/09
Porter DE et al. - After multivariate analysis, however, only NF1 and tumour volume more than 200 m remained independent predictors of poor outcome. The authors recommend that NF1 be taken into account during MPNST staging.
Related Articles
Malignant Peripheral Nerve Sheath Tumor of the Renal Pelvis
Urologia Internationalis, 10/22/09
Relevance Score: 85%
Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors
Neuro-Oncology, 10/06/09
Relevance Score: 84%
Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis
Oncogene, 11/12/09
Relevance Score: 80%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
DO Intracranial Neoplasms Differ in Ollier Disease and Maffucci Syndrome? An in-Depth Analysis of the Literature
Neurosurgery, 12/07/09
Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy
Journal of Neuro-Oncology, 12/07/09
High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system
Journal of Neuro-Oncology, 12/07/09
Sponsor
Article Search
Sponsor